Inter Pharma PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	280.64	184.6	412.39	776.42	173.87
Short-Term Investments	1.01	0.93	0.86	0.83	0.8
Cash & Short-Term Investments	281.65	185.53	413.25	777.25	174.67
Cash Growth	51.81%	-55.10%	-46.83%	344.99%	14.09%
Accounts Receivable	374.86	376.06	337.32	340.3	258.11
Other Receivables	81.82	71.37	87.74	51.89	34.08
Receivables	456.68	447.43	425.06	392.2	292.25
Inventory	358.78	339.49	351.82	332.98	192
Other Current Assets	8.8	9.35	12.72	12.78	7.7
Total Current Assets	1,106	981.8	1,203	1,515	666.61
Property, Plant & Equipment	1,210	1,150	929.27	880.77	457.32
Long-Term Investments	36.29	41.78	43.37	9.35	10.12
Goodwill	563.1	563.1	477.85	477.85	22.16
Other Intangible Assets	219.82	217.36	197.36	167.79	55.1
Long-Term Accounts Receivable	2.06	-	-	-	-
Long-Term Deferred Tax Assets	20.94	20.17	15.91	9.81	8.98
Other Long-Term Assets	80.47	52.16	85.75	29.52	106.76
Total Assets	3,239	3,027	2,952	3,090	1,327
Accounts Payable	212.98	184.6	200.52	193.79	69.65
Accrued Expenses	60.52	46.03	47.06	34.74	15.92
Short-Term Debt	119.33	79.91	46.34	48.73	131.01
Current Portion of Long-Term Debt	62.42	55.2	54.43	72.51	35.62
Current Portion of Leases	32.83	26.64	38.89	30.46	0.57
Current Income Taxes Payable	24.53	11.84	4.11	25.18	14.8
Current Unearned Revenue	5.33	4.59	-	-	-
Other Current Liabilities	120.08	117.47	87.39	92.55	68.06
Total Current Liabilities	638.02	526.29	478.75	497.95	335.63
Long-Term Debt	124.45	167.19	205.46	319.61	187.06
Long-Term Leases	61.91	65.5	54.83	67.69	1.9
Pension & Post-Retirement Benefits	48.85	40.88	32.75	31.14	15.41
Long-Term Deferred Tax Liabilities	54.61	60.88	59.21	55.33	3.53
Other Long-Term Liabilities	11.99	8.32	3.66	2.14	-
Total Liabilities	939.83	869.06	834.65	973.86	543.54
Common Stock	302.67	302.67	186.26	186.26	149.01
Additional Paid-In Capital	1,498	1,498	1,498	1,498	492.09
Retained Earnings	254.69	131.79	225.25	238.26	116.85
Comprehensive Income & Other	3.7	3.7	3.7	3.7	3.7
Total Common Equity	2,059	1,936	1,913	1,926	761.64
Minority Interest	239.94	221.66	204.53	190.25	21.86
Shareholders' Equity	2,299	2,158	2,118	2,116	783.5
Total Liabilities & Equity	3,239	3,027	2,952	3,090	1,327
Total Debt	400.94	394.45	399.95	539	356.17
Net Cash (Debt)	-119.29	-208.92	13.3	238.25	-181.5
Net Cash Growth	-	-	-94.42%	-	-
Net Cash Per Share	-0.20	-0.35	0.02	0.45	-0.38
Filing Date Shares Outstanding	605.34	605.34	605.35	605.35	484.27
Total Common Shares Outstanding	605.34	605.34	605.35	605.35	484.27
Working Capital	467.9	455.51	724.1	1,017	330.98
Book Value Per Share	3.40	3.20	3.16	3.18	1.57
Tangible Book Value	1,276	1,156	1,238	1,281	684.38
Tangible Book Value Per Share	2.11	1.91	2.05	2.12	1.41
Land	333.9	333.9	327.63	327.63	183.25
Buildings	629.85	534.98	430.08	404.55	177.13
Machinery	398.23	380.51	346.66	310.51	148.3
Construction In Progress	162.42	174.85	57.17	15.97	0.33

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.